Attention Deficit Hyperactivity Disorder (ADHD) Assessment Service for NHS Shropshire Telford and Wrekin Integrated Care Board

Description

This is an advertisement for soft market testing to gauge market interest which will influence future commissioning and procurement direction. NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) are looking to seek expressions of interest and to engage with suitably qualified and experienced Providers with regards to the commissioning of a • Attention Deficit Hyperactivity Disorder(ADHD) Assessment Service The ICB are looking to host a Market Engagement Event with potential providers via Microsoft Teams on Thursday 22nd February 2024, timings to be confirmed. Should you be interest in attending please respond via Atamis no later than 16:00 hours on Friday 16th February 2024. Lot 1: This is an advertisement for soft market testing to gauge market interest which will influence future commissioning and procurement direction. NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) are looking to seek expressions of interest and to engage with suitably qualified and experienced Providers with regards to the commissioning of a • Attention Deficit Hyperactivity Disorder(ADHD) Assessment Service The ICB are looking to host a Market Engagement Event with potential providers via Microsoft Teams on Thursday 22nd February 2024, timings to be confirmed. The Service will consist of: • Providing a specialist assessment and diagnostic service to adults with a suspected ADHD residing within the local areas as defined by the ICB commissioning boundaries. • This service is for the triage ,assessment, diagnosis and establishing treatment for adult patients with ADHD symptoms and is designed to provide a safe and effective service within the community to patients across STW with a suspected ADHD diagnosis which may require pharmacological and/or non-pharmacological treatment for ADHD as appropriate on confirmed diagnosis. • This service will assess and diagnose individuals with suspected ADHD across STW who do not have serious mental health comorbidities. To provide a safe and effective service the service will: • Provide initial assessment and timely diagnosis of ADHD in adults and establish a treatment plan to include pharmacological and/or non-pharmacological treatment which also addresses the individuals psychological, behavioural, and occupational or educational needs. • Provide relevant advice, guidance, support and signposting to appropriate organisations and other professionals as appropriate. • Initiation of medication that aligns to NHS STW ICS local health formulary: Formulary(shropshireandtelfordformulary.nhs.uk). • Provide the specialist element of oversight of prescribing including all baseline physical health checks and ongoing monitoring as appropriate as detailed by the Integrated Care Protocol (ICP) prior to transfer/acceptance to oversight/monitoring service or any other appropriate provider. • Provide guidance on self-help strategies and recommendations for individuals in support of self-care. It is anticipated that any future Contract would be for a period of 1 year with the option to extend for up to a further 12 months with an estimated value of £3,200,000.00. NHS Standard Terms and Conditions would apply. Should you be interest in attending please respond via Atamishttps://health-family.force.com/s/Welcome no later than 16:00 hours on Friday 16th February 2024. The ICB are aware of their transparency obligations under the Provider Selection Regime. Please note for those providers expressing interest to attend this market engagement event, this does not guarantee that they will not be required to register for any future provider selection process, and they should not rely on their response to this Expressions of Interest notice as confirmation that the ICB will proceed further.